Literature DB >> 27423427

Determinants of hepatic effector CD8+ T cell dynamics.

Alexandre Pierre Benechet1, Matteo Iannacone2.   

Abstract

Antigen-specific effector CD8+ T cells play a critical role in controlling hepatic infections, such as the one caused by hepatitis B virus (HBV). We review here recent results where we coupled advanced dynamic imaging with dedicated mouse models of HBV pathogenesis to show that circulating effector CD8+ T cells aimed at viral clearance initially arrest in liver sinusoids by preferentially docking onto platelets that have previously adhered to liver sinusoids. Upon detachment from platelets, effector CD8+ T cells crawl within the sinusoids irrespective of bloodstream direction, and probe underlying hepatocytes for the presence of antigen by extending filopodia-like protrusions through the sinusoidal fenestrae. Effector CD8+ T cells recognize hepatocellular antigen and perform effector functions (i.e., IFN-γ production and hepatocyte killing) while still in the intravascular space. They later extravasate in the parenchyma. Finally, we provide our perspective on how, in the next few years, intravital microscopy might shed new light on yet unresolved issues with particular regard to identifying the determinants of hepatic effector CD8+ T cell trafficking, antigen recognition and effector functions during hepatocellular carcinoma and understanding the mechanisms whereby intrahepatic T cell priming induces functionally defective T cell responses. A better understanding of how adaptive immunity mediates pathogen clearance and tumor elimination may lead to improved vaccination and treatment strategies for immunotherapy of infectious diseases and cancer. Copyright Â
© 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD8(+) T cells; Hepatitis B virus; Intravital imaging; Leukocyte trafficking; Mouse models; Platelets

Mesh:

Year:  2016        PMID: 27423427     DOI: 10.1016/j.jhep.2016.07.011

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  9 in total

1.  Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy.

Authors:  Shida Pan; Yingying Yu; Siyu Wang; Bo Tu; Yingjuan Shen; Qin Qiu; Xiaomeng Liu; Nan Su; Yanmei Zuo; Junqing Luan; Ji Yuan Zhang; Ming Shi; Fanping Meng; Fu-Sheng Wang
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

Review 2.  Immunobiology and pathogenesis of hepatitis B virus infection.

Authors:  Matteo Iannacone; Luca G Guidotti
Journal:  Nat Rev Immunol       Date:  2021-05-17       Impact factor: 53.106

Review 3.  CTLA‑4 interferes with the HBV‑specific T cell immune response (Review).

Authors:  Hui Cao; Ruiwen Zhang; Wei Zhang
Journal:  Int J Mol Med       Date:  2018-05-17       Impact factor: 4.101

4.  An optimized protocol for the generation of HBV viral antigen-specific T lymphocytes from pluripotent stem cells.

Authors:  Mohammad Haque; Xiaofang Xiong; Fengyang Lei; Jugal Kishore Das; Jianxun Song
Journal:  STAR Protoc       Date:  2021-01-12

Review 5.  Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies.

Authors:  Julie Giraud; Domitille Chalopin; Jean-Frédéric Blanc; Maya Saleh
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

Review 6.  Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances.

Authors:  Kathrine S Rallis; Dimitrios Makrakis; Ioannis A Ziogas; Georgios Tsoulfas
Journal:  World J Clin Oncol       Date:  2022-06-24

Review 7.  Hyaluronan and Its Receptors as Regulatory Molecules of the Endothelial Interface.

Authors:  Kimberly A Queisser; Rebecca A Mellema; Aaron C Petrey
Journal:  J Histochem Cytochem       Date:  2020-09-01       Impact factor: 2.479

8.  Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HBV Replication through Production of IFN-γ and TNF-⍺.

Authors:  Mohammad Haque; Fengyang Lei; Xiaofang Xiong; Yijie Ren; Anil Kumar; Jugal Kishore Das; Xingcong Ren; Deyu Fang; Paul de Figueiredo; Jin-Ming Yang; Jianxun Song
Journal:  iScience       Date:  2020-07-01

Review 9.  The Immunological Basis of Liver Allograft Rejection.

Authors:  Vincenzo Ronca; Grace Wootton; Chiara Milani; Owen Cain
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.